PNV 3.56% $2.58 polynovo limited

The Clinicians Speak, page-311

  1. 1,200 Posts.
    lightbulb Created with Sketch. 214
    https://digital.library.adelaide.edu.au/dspace/handle/2440/136737
    The Development of a Tissue-Engineered Skin Composite Utilising a Biodegradable Polyurethane Scaffold in a Novel Bioreactor for the Treatment of Extensive, Full-Thickness Burns

    New research thesis from Bronwyn Dearman from Adelaide Medical School (advisor was Dr Greenwood)

    The changes in burn care over the last two decades has seen the percentage of survival burn increase, requiring the need to seek alternative tissue sources. With this in mind, a two stage strategy has been developed to assist with this challenge. The first stage, a biodegradable temporising matrix (BTM) was developed to temporise the wound, followed by the second stage of definitive wound coverage with a laboratory fabricated skin composite, composite cultured skin (CCS)
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.58
Change
-0.095(3.56%)
Mkt cap ! $1.753B
Open High Low Value Volume
$2.62 $2.62 $2.53 $2.525M 984.5K

Buyers (Bids)

No. Vol. Price($)
17 2660 $2.57
 

Sellers (Offers)

Price($) Vol. No.
$2.58 22819 38
View Market Depth
Last trade - 12.54pm 25/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.